-
HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains.
J Immunol. 1997 Oct 15;159(8):3792-8
PMID: 9378966
-
X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II.
Immunity. 1997 Oct;7(4):473-81
PMID: 9354468
-
Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.
Nat Immunol. 2001 Jun;2(6):501-7
PMID: 11376336
-
Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.
EMBO J. 2005 Sep 7;24(17):2968-79
PMID: 16079912
-
A functional and structural basis for TCR cross-reactivity in multiple sclerosis.
Nat Immunol. 2002 Oct;3(10):940-3
PMID: 12244309
-
The orientation of a T cell receptor to its MHC class II:peptide ligands.
J Immunol. 1997 Nov 1;159(9):4395-402
PMID: 9379037
-
Alternate interactions define the binding of peptides to the MHC molecule IA(b).
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8820-5
PMID: 12084926
-
Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.
Nature. 1992 Apr 30;356(6372):799-801
PMID: 1574119
-
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
Nature. 1993 Jul 1;364(6432):33-9
PMID: 8316295
-
The wide diversity and complexity of peptides bound to class II MHC molecules.
Curr Opin Immunol. 2006 Feb;18(1):70-7
PMID: 16316750
-
Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation.
J Exp Med. 1995 Sep 1;182(3):779-87
PMID: 7650484
-
Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.
Immunity. 2000 Jun;12(6):699-710
PMID: 10894169
-
Large-scale sequence comparisons reveal unusually high levels of variation in the HLA-DQB1 locus in the class II region of the human MHC.
J Mol Biol. 1998 Sep 11;282(1):71-97
PMID: 9733642
-
A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.
Nature. 1988 Apr 28;332(6167):845-50
PMID: 3258651
-
Immunological properties of the thymopentin-like fragments of HLA-DQ.
Mol Immunol. 1996 Aug;33(11-12):903-8
PMID: 8960113
-
Allelic variation in transcription modulates MHC class II expression and function.
Microbes Infect. 1999 Sep;1(11):919-27
PMID: 10614010
-
Biochemical characterization of proteins that co-purify with class II antigens of the murine MHC.
J Immunol. 1988 Mar 15;140(6):1930-8
PMID: 3162251
-
The immunological synapse: a molecular machine controlling T cell activation.
Science. 1999 Jul 9;285(5425):221-7
PMID: 10398592
-
Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium.
Nature. 1999 Oct 28;401(6756):921-3
PMID: 10553908
-
Trafficking of MHC class II molecules in the late secretory pathway.
Curr Opin Immunol. 2002 Feb;14(1):30-5
PMID: 11790530
-
A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain.
J Immunol. 1999 Sep 1;163(5):2704-12
PMID: 10453012
-
Nucleotide sequence, polymorphism, and evolution of ovine MHC class II DQA genes.
Immunogenetics. 1991;34(2):69-79
PMID: 1678367
-
MHC class II molecules that lack cytoplasmic domains are associated with the cytoskeleton.
J Immunol. 1994 Oct 15;153(8):3398-407
PMID: 7930565
-
Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy.
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1999-2004
PMID: 14769912
-
Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.
Nat Struct Biol. 1997 Jul;4(7):527-31
PMID: 9228944
-
Crystal structure of I-Ak in complex with a dominant epitope of lysozyme.
Immunity. 1998 Mar;8(3):305-17
PMID: 9529148
-
Structure and evolution of the promoter regions of the DQA genes.
Immunogenetics. 1993;37(5):364-72
PMID: 8428769
-
T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4.
J Biol Chem. 2001 Feb 23;276(8):5659-67
PMID: 11106664
-
Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules.
J Exp Med. 1994 Feb 1;179(2):763-8
PMID: 8294884
-
Molecular basis for HLA-DQ associations with IDDM.
Diabetes. 1998 Aug;47(8):1177-84
PMID: 9703314
-
A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.
Science. 2000 Apr 21;288(5465):505-11
PMID: 10775108
-
MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8.
Nature. 1992 Apr 30;356(6372):796-8
PMID: 1574118
-
MHC ligands and peptide motifs: first listing.
Immunogenetics. 1995;41(4):178-228
PMID: 7890324
-
Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
J Exp Med. 2002 Jul 15;196(2):173-83
PMID: 12119342
-
The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.
J Immunol. 1998 Oct 1;161(7):3282-91
PMID: 9759843
-
The immune function of MHC class II molecules mutated in the putative superdimer interface.
Mol Cell Biochem. 2005 May;273(1-2):1-9
PMID: 16013435
-
Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM.
Diabetologia. 1995 Nov;38(11):1251-61
PMID: 8582533
-
Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1.
EMBO J. 2000 Nov 1;19(21):5611-24
PMID: 11060013
-
Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes.
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):241-4
PMID: 8552613
-
Not just any T cell receptor will do.
Immunity. 2003 Jan;18(1):7-11
PMID: 12530971
-
A molecular basis for MHC class II--associated autoimmunity.
Science. 1988 May 20;240(4855):1003-9
PMID: 3368786
-
Ancestral major histocompatibility complex DRB genes beget conserved patterns of localized polymorphisms.
Proc Natl Acad Sci U S A. 1996 May 28;93(11):5380-3
PMID: 8643583
-
Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR.
J Struct Biol. 1996 Sep-Oct;117(2):145-63
PMID: 8931340
-
Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor.
J Exp Med. 1998 Nov 2;188(9):1633-40
PMID: 9802975
-
Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii.
EMBO J. 1998 Dec 1;17(23):6812-8
PMID: 9843486
-
Greek Cypriot allele and genotype frequencies for Amplitype PM-DQA1 and D1S80 loci.
J Forensic Sci. 1998 May;43(3):661-4
PMID: 9608705
-
Disruption of the CD4-major histocompatibility complex class II interaction blocks the development of CD4(+) T cells in vivo.
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4493-8
PMID: 9539765
-
Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein.
J Exp Med. 1998 Oct 19;188(8):1511-20
PMID: 9782128
-
Interactions between MHC molecules and co-receptors of the TCR.
Curr Opin Immunol. 2002 Feb;14(1):75-83
PMID: 11790535
-
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.
J Exp Med. 1989 Jan 1;169(1):345-50
PMID: 2909659
-
Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus.
Diabetologia. 1993 May;36(5):371-7
PMID: 8314439
-
Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
Int Immunol. 2000 Aug;12 (8):1157-66
PMID: 10917890
-
Ligand-specific oligomerization of T-cell receptor molecules.
Nature. 1997 Jun 5;387(6633):617-20
PMID: 9177351
-
A role for MHC class II antigens in B-cell activation.
J Autoimmun. 1989 Jun;2 Suppl:215-23
PMID: 2789060
-
Structures of an MHC class II molecule with covalently bound single peptides.
Science. 1996 May 17;272(5264):1001-4
PMID: 8638119
-
Mutational analysis of critical residues determining antigen presentation and activation of HLA-DQ0602 restricted T-cell clones.
Hum Immunol. 2002 Mar;63(3):185-93
PMID: 11872236
-
Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells.
Am J Med Genet. 2002 May 30;115(1):37-47
PMID: 12116175
-
Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity.
Immunity. 2005 Jan;22(1):81-92
PMID: 15664161
-
Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T cell model.
Immunity. 2002 Oct;17(4):425-36
PMID: 12387737
-
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins.
Eur J Immunol. 1996 Nov;26(11):2657-65
PMID: 8921952
-
Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity.
J Exp Med. 2002 Mar 4;195(5):571-81
PMID: 11877480
-
Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted.
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2598-602
PMID: 1826057
-
The specificity of TCR/pMHC interaction.
Curr Opin Immunol. 2002 Feb;14(1):52-65
PMID: 11790533
-
The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.
Immunity. 1998 Sep;9(3):377-83
PMID: 9768757
-
Differential clustering of CD4 and CD3zeta during T cell recognition.
Science. 2000 Aug 25;289(5483):1349-52
PMID: 10958781
-
Monocytes are differentially activated through HLA-DR, -DQ, and -DP molecules via mitogen-activated protein kinases.
J Immunol. 2001 Feb 15;166(4):2202-8
PMID: 11160273
-
The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
J Exp Med. 1991 Mar 1;173(3):759-62
PMID: 1847724
-
MHC class II proteins and disease: a structural perspective.
Nat Rev Immunol. 2006 Apr;6(4):271-82
PMID: 16557259
-
The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers.
Immunity. 2000 Mar;12(3):241-50
PMID: 10755611
-
Genomic organization of the mammalian MHC.
Annu Rev Immunol. 2003;21:629-57
PMID: 12500978
-
Genetics of demyelinating diseases.
Brain Pathol. 1996 Jul;6(3):289-302
PMID: 8864285
-
Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.
Nature. 2001 Mar 29;410(6828):608-11
PMID: 11279502
-
The lysosomal cysteine proteases in MHC class II antigen presentation.
Immunol Rev. 2005 Oct;207:229-41
PMID: 16181340
-
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule.
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10799-804
PMID: 11535811
-
HLA informatics. Accessing HLA sequences from sequence databases.
Methods Mol Biol. 2003;210:3-21
PMID: 12412448
-
HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus.
Diabetologia. 1981 Aug;21(2):108-15
PMID: 6167481
-
Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation.
J Immunol. 2001 Jan 15;166(2):800-8
PMID: 11145653
-
Altered TCR signaling from geometrically repatterned immunological synapses.
Science. 2005 Nov 18;310(5751):1191-3
PMID: 16293763
-
Regulation of memory CD4 T cell adhesion by CD4-MHC class II interaction.
J Immunol. 1997 Sep 15;159(6):2567-73
PMID: 9300674
-
Immunosuppressory mini-regions of HLA-DP and HLA-DR.
Mol Immunol. 1999 Jun;36(8):525-33
PMID: 10475607
-
Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au.
Immunity. 2002 Jul;17(1):83-94
PMID: 12150894
-
Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):734-8
PMID: 8570625
-
Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
J Mol Biol. 2000 Nov 24;304(2):177-88
PMID: 11080454
-
Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes.
J Exp Med. 1991 Jan 1;173(1):181-92
PMID: 1985121
-
Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination.
Nature. 2006 Nov 2;444(7115):115-8
PMID: 17051151
-
RGD sequences in several receptor proteins: novel cell adhesion function of receptors?
Int J Biol Macromol. 1998 Feb;22(1):51-7
PMID: 9513816
-
Clustering of MHC-peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains.
Immunol Rev. 2002 Nov;189:136-51
PMID: 12445271
-
HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation.
J Immunol. 1993 Mar 15;150(6):2263-72
PMID: 8450211
-
The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
Nature. 1995 Nov 30;378(6556):457-62
PMID: 7477400
-
Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death.
J Immunol. 1999 May 15;162(10):5973-80
PMID: 10229835
-
The role of class II molecules in human B cell activation. Association with phosphatidyl inositol turnover, protein tyrosine phosphorylation, and proliferation.
J Immunol. 1990 May 15;144(10):3684-92
PMID: 1692059
-
Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif.
J Mol Biol. 2003 Feb 28;326(4):1157-74
PMID: 12589760
-
Integrins: versatility, modulation, and signaling in cell adhesion.
Cell. 1992 Apr 3;69(1):11-25
PMID: 1555235
-
A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.
J Clin Invest. 1990 Apr;85(4):1315-9
PMID: 2318983
-
Association of distinct tetraspanins with MHC class II molecules at different subcellular locations in human immature dendritic cells.
Int Immunol. 2001 Feb;13(2):127-34
PMID: 11157846
-
The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules.
J Immunol. 1993 Oct 15;151(8):4090-7
PMID: 8409388
-
Inhibition of MHC class II expression and immune responses by c-MIR.
J Immunol. 2006 Jul 1;177(1):341-54
PMID: 16785530
-
Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor.
Nat Immunol. 2005 May;6(5):490-6
PMID: 15821740
-
Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.
J Clin Invest. 2005 Aug;115(8):2268-76
PMID: 16075062
-
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
Eur J Immunol. 1996 Nov;26(11):2764-72
PMID: 8921967
-
Immunological synapses are versatile structures enabling selective T cell polarization.
Immunity. 2005 Feb;22(2):185-94
PMID: 15723807
-
Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1540-4
PMID: 8643668
-
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.
Nature. 1994 Mar 17;368(6468):215-21
PMID: 8145819
-
Novel SLA-DQ alleles and their recombinant molecules in xenogeneic stimulation of human T cells.
Transpl Immunol. 2005 Jun;14(2):83-9
PMID: 15935298
-
Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.
Immunogenetics. 1997;46(6):484-92
PMID: 9321428
-
Modelling of the MHC II allele I-A(g7) of NOD mouse: pH-dependent changes in specificity at pockets 9 and 6 explain several of the unique properties of this molecule.
Diabetologia. 2000 May;43(5):609-24
PMID: 10855536
-
Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues.
Immunity. 1998 Mar;8(3):319-29
PMID: 9529149
-
Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4175-9
PMID: 15020763
-
The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
Structure. 1997 Oct 15;5(10):1385-96
PMID: 9351812
-
Open reading frame sequencing and structure-based alignment of polypeptides encoded by RT1-Bb, RT1-Ba, RT1-Db, and RT1-Da alleles.
Immunogenetics. 2004 Nov;56(8):585-96
PMID: 15517241
-
Type 1 diabetes in Japan.
Diabetologia. 2006 May;49(5):828-36
PMID: 16568259
-
Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen.
J Immunol. 2006 Sep 15;177(6):3884-92
PMID: 16951351
-
Signaling in the immunological synapse: defining the optimal size.
Immunity. 2006 Jul;25(1):11-3
PMID: 16860751
-
The cytoplasmic tail of invariant chain modulates antigen processing and presentation.
Eur J Immunol. 2003 Feb;33(2):277-86
PMID: 12548558
-
The crystal structure of a T cell receptor in complex with peptide and MHC class II.
Science. 1999 Dec 3;286(5446):1913-21
PMID: 10583947
-
The T cell receptor for antigen: signaling and ligand discrimination.
J Biol Chem. 2001 Sep 21;276(38):35223-6
PMID: 11435448
-
HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans.
Nature. 1987 Jun 4-10;327(6121):426-30
PMID: 3108669